BNP

B-Type Natriuretic Peptide / NT-proBNP

Q: What is the difference between BNP and NT-proBNP?

Both are released from the same precursor molecule when the heart is stressed. BNP is the biologically active hormone with a 20-minute half-life, while NT-proBNP is the inactive fragment with a 120-minute half-life. They are not interchangeable—their reference ranges and cutoffs differ significantly. NT-proBNP is more affected by age and kidney function, while BNP levels can be lowered by the drug sacubitril (in Entresto), which inhibits BNP breakdown. Your doctor will consistently use one or the other for monitoring.

Q: Can BNP be elevated without heart failure?

Yes. BNP and NT-proBNP can be elevated in atrial fibrillation, pulmonary embolism, pulmonary hypertension, severe sepsis, chronic kidney disease, and advanced age—all of which cause cardiac wall stress without necessarily indicating heart failure. The test is most powerful for ruling out heart failure (high negative predictive value) rather than ruling it in. Clinical context, echocardiography, and other testing are needed to confirm the diagnosis.

Q: Why might BNP be low in obese patients with heart failure?

Adipose tissue expresses natriuretic peptide clearance receptors (NPR-C) that actively remove BNP from the circulation. Consequently, obese patients with genuine heart failure may have BNP levels that are lower than expected for their degree of cardiac dysfunction. Some guidelines suggest using lower BNP cutoffs in obese patients or relying more on NT-proBNP, which is less affected by adiposity. If clinical suspicion for heart failure is high, pursue echocardiography regardless of the BNP level.

Cardíaco

Última revisão: 7 de abril de 2026. Abordagem de fontes: contexto padrão de interpretação laboratorial, material médico de referência e orientações clínicas ou de saúde pública quando relevantes.

O que é B-Type Natriuretic Peptide / NT-proBNP?

B-type natriuretic peptide (BNP) and its amino-terminal fragment NT-proBNP are cardiac neurohormones released primarily from ventricular cardiomyocytes in response to myocardial wall stress caused by volume overload or pressure overload. When the ventricles are stretched, the precursor molecule proBNP is cleaved into the biologically active BNP (32 amino acids) and the inactive NT-proBNP (76 amino acids). BNP acts on natriuretic peptide receptors to promote vasodilation, natriuresis (sodium excretion in urine), diuresis, and suppression of the renin-angiotensin-aldosterone system and sympathetic nervous system—all of which serve to reduce cardiac workload.

BNP and NT-proBNP are the cornerstone biomarkers for the diagnosis, risk stratification, and management of heart failure. They are particularly valuable in the emergency department for differentiating cardiac from pulmonary causes of acute dyspnea. NT-proBNP has a longer half-life (120 minutes vs. 20 minutes for BNP) and higher circulating concentrations, making it easier to measure, but it is more affected by renal function and age. Both markers have well-established age- and sex-specific cutoffs, and serial measurements are used to guide heart failure therapy and predict outcomes.

Por que isso importa

BNP and NT-proBNP are among the most important biomarkers in cardiovascular medicine. A normal BNP or NT-proBNP level has a very high negative predictive value for heart failure—meaning if the level is normal, heart failure is very unlikely as the cause of a patient's symptoms. Elevated levels not only support the diagnosis of heart failure but also correlate with its severity (higher New York Heart Association class corresponds to higher levels). Serial monitoring helps clinicians titrate medications and detect worsening before clinical symptoms appear. These markers also provide prognostic information in acute coronary syndromes, pulmonary embolism, and sepsis.

Faixas de referência normais

Grupo	Faixa	Unidade
BNP: Adults < 75 years	<100	pg/mL
BNP: Adults ≥ 75 years	<200	pg/mL
NT-proBNP: Adults < 75 years	<125	pg/mL
NT-proBNP: Adults ≥ 75 years	<450	pg/mL
NT-proBNP: Heart failure exclusion cutoff (acute dyspnea)	<300	pg/mL

As faixas de referência podem variar entre laboratórios. Sempre compare seus resultados com as faixas fornecidas pelo seu local de exame.

O que significam níveis altos de BNP

Causas comuns

Heart failure (systolic or diastolic)
Acute coronary syndromes
Pulmonary embolism
Atrial fibrillation or other arrhythmias
Valvular heart disease (aortic stenosis, mitral regurgitation)
Hypertensive crisis
Pulmonary hypertension
Chronic kidney disease (especially NT-proBNP)
Sepsis and critical illness
Cardiac amyloidosis

Possíveis sintomas

Shortness of breath (dyspnea), especially on exertion or when lying flat
Swelling of the legs, ankles, or abdomen (edema)
Fatigue and exercise intolerance
Rapid or irregular heartbeat
Persistent cough or wheezing
Weight gain from fluid retention
Difficulty sleeping due to breathlessness (orthopnea, PND)

O que fazer: Elevated BNP or NT-proBNP in the setting of dyspnea strongly suggests heart failure. Further evaluation should include echocardiography to assess cardiac structure and function, an electrocardiogram, chest X-ray, and renal function tests. Treatment of heart failure follows guideline-directed medical therapy including ACE inhibitors or ARNIs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. Serial BNP/NT-proBNP monitoring helps guide therapy intensity and detect clinical deterioration early.

O que significam níveis baixos de BNP

Causas comuns

Obesity (BNP is paradoxically lower in obese patients due to increased clearance by adipose tissue natriuretic peptide receptors)
Flash pulmonary edema with very acute onset (BNP may not have risen yet)
Constrictive pericarditis (in some cases)

Possíveis sintomas

Low BNP itself does not cause symptoms
A normal or low BNP in the right clinical context is reassuring against heart failure

O que fazer: Low BNP/NT-proBNP effectively rules out heart failure as the cause of symptoms in most clinical scenarios. In obese patients, be aware that BNP cutoffs may need to be adjusted downward, and a "normal" BNP does not completely exclude heart failure. If clinical suspicion remains high despite low natriuretic peptides, proceed with echocardiography.

Quando o exame de BNP é recomendado?

When evaluating acute dyspnea in the emergency department to differentiate cardiac from pulmonary causes
For diagnosis and staging of heart failure
To guide and monitor heart failure treatment (serial measurements)
As a prognostic marker in acute coronary syndromes or pulmonary embolism
When screening high-risk patients for cardiac dysfunction (e.g., before cardiotoxic chemotherapy)

Perguntas frequentes

Both are released from the same precursor molecule when the heart is stressed. BNP is the biologically active hormone with a 20-minute half-life, while NT-proBNP is the inactive fragment with a 120-minute half-life. They are not interchangeable—their reference ranges and cutoffs differ significantly. NT-proBNP is more affected by age and kidney function, while BNP levels can be lowered by the drug sacubitril (in Entresto), which inhibits BNP breakdown. Your doctor will consistently use one or the other for monitoring.

Yes. BNP and NT-proBNP can be elevated in atrial fibrillation, pulmonary embolism, pulmonary hypertension, severe sepsis, chronic kidney disease, and advanced age—all of which cause cardiac wall stress without necessarily indicating heart failure. The test is most powerful for ruling out heart failure (high negative predictive value) rather than ruling it in. Clinical context, echocardiography, and other testing are needed to confirm the diagnosis.

Adipose tissue expresses natriuretic peptide clearance receptors (NPR-C) that actively remove BNP from the circulation. Consequently, obese patients with genuine heart failure may have BNP levels that are lower than expected for their degree of cardiac dysfunction. Some guidelines suggest using lower BNP cutoffs in obese patients or relying more on NT-proBNP, which is less affected by adiposity. If clinical suspicion for heart failure is high, pursue echocardiography regardless of the BNP level.

Biomarcadores relacionados

cTnTroponina CKCreatine Kinase CrCreatinina D-DD-dímero

Referências e abordagem de revisão

As páginas do glossário de biomarcadores são explicações educativas e devem ser interpretadas junto com as faixas de referência e observações fornecidas pelo seu laboratório e pelo seu médico. Para conhecer nossos padrões editoriais e processo de revisão, veja nossa Política editorial e a nossa revisão de conteúdo.

Quer analisar seus níveis de BNP?

Envie seus resultados de exames para receber uma análise instantânea com IA de todos os seus biomarcadores.

Enviar resultados de exames →

Aviso médico: Estas informações são apenas educativas e não substituem orientação, diagnóstico ou tratamento médico profissional. As faixas de referência podem variar entre laboratórios. Sempre converse com seu profissional de saúde sobre a interpretação dos seus resultados específicos.